Financials LumiraDx Limited

Equities

LMDXF

KYG5709L1095

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 03:56:20 2024-04-26 pm EDT 5-day change 1st Jan Change
0.017 USD +10.68% Intraday chart for LumiraDx Limited -15.00% -72.97%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 2,252 285.9
Enterprise Value (EV) 1 2,452 633.1
P/E ratio -14.4 x -0.57 x
Yield - -
Capitalization / Revenue 5,342,677 x 1,123,563 x
EV / Revenue 5,817,897 x 2,487,758 x
EV / EBITDA -27,517,984 x -3,253,310 x
EV / FCF -10,684,898 x -12,590,045 x
FCF Yield -0% -0%
Price to Book 13.8 x -2.73 x
Nbr of stocks (in thousands) 252,700 317,689
Reference price 2 8.910 0.9000
Announcement Date 4/13/22 5/1/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - 25.39 23.14 139.2 421.4 254.5
EBITDA - -86.21 -108.7 -92.62 -89.1 -194.6
EBIT - -91.72 -115 -100.7 -109.2 -221.7
Operating Margin - -361.31% -497.02% -72.38% -25.91% -87.14%
Earnings before Tax (EBT) 1 - -127.3 -142.6 -250.9 -97.91 -443.3
Net income 1 - -115.2 -132.8 -241 -100.9 -447.8
Net margin - -453.61% -573.88% -173.18% -23.95% -175.97%
EPS - -1.390 -1.621 -2.931 -0.6200 -1.590
Free Cash Flow - - -92.79 -223.2 -229.5 -50.28
FCF margin - - -400.97% -160.42% -54.45% -19.76%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/21/18 10/14/20 10/14/20 7/7/21 4/13/22 5/1/23
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 109.1 118.3 125.6 44.73 42.22 41.12 22.17 21
EBITDA - - - - - - - -
EBIT 1 -19.85 -22.11 -31.45 -80.46 -57.93 -151.6 -47.22 -48.43
Operating Margin -18.2% -18.69% -25.03% -179.89% -137.23% -368.69% -212.94% -230.58%
Earnings before Tax (EBT) 1 85.77 -36.92 -53.45 -148.1 -141.3 -98.02 -43.64 -49.38
Net income 1 84.74 -37.34 -55.75 -147.5 -143.5 -102.2 -44.21 -49.74
Net margin 77.68% -31.58% -44.38% -329.69% -339.86% -248.53% -199.39% -236.8%
EPS 2 0.4600 -0.1500 -0.2200 -0.5800 -0.4700 -0.3200 -0.1400 -0.1600
Dividend per Share - - - - - - - -
Announcement Date 11/10/21 3/10/22 5/11/22 8/18/22 11/9/22 3/21/23 5/16/23 8/24/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 14.2 96.3 224 591 200 347
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - -1.117 x -2.064 x -6.382 x -2.248 x -1.784 x
Free Cash Flow - - -92.8 -223 -229 -50.3
ROE (net income / shareholders' equity) - 675% 142% 91.3% 94.8% -1,564%
ROA (Net income/ Total Assets) - -42% -28.3% -16.5% -11.8% -25.5%
Assets 1 - 274.4 469.7 1,464 857.6 1,754
Book Value Per Share - -0.4100 -1.860 -4.560 0.6400 -0.3300
Cash Flow per Share - 2.070 1.700 1.930 0.5200 0.3100
Capex - 8.44 10.6 64.4 106 25
Capex / Sales - 33.23% 45.91% 46.27% 25.23% 9.82%
Announcement Date 6/21/18 10/14/20 10/14/20 7/7/21 4/13/22 5/1/23
1USD in Million
Estimates
  1. Stock Market
  2. Equities
  3. LMDXF Stock
  4. Financials LumiraDx Limited